Literature DB >> 33298303

It's not just the money: The role of treatment ideology in publicly funded substance use disorder treatment.

Rebecca E Stewart1, Courtney Benjamin Wolk2, Geoffrey Neimark3, Ridhi Vyas2, Jordyn Young4, Chris Tjoa5, Kyle Kampman2, David T Jones6, David S Mandell2.   

Abstract

Medications for opioid use disorder (MOUD) are a first-line treatment for opioid use disorder, yet national surveys indicate that most substance use treatment facilities do not offer MOUD. This article presents the results of a qualitative analysis of interviews with leaders from 25 treatment organizations in Philadelphia, Pennsylvania, that investigated attitudes and barriers toward MOUD. Most treatment organizations that we interviewed are adopting at least one MOUD, suggesting that Philadelphia exceeds the national average of organizations with MOUD capacity. Leaders indicated that both practical resources and ideological barriers thwart adoption and implementation of MOUD in publicly funded substance use disorder treatment agencies. Organizations that had recently adopted MOUDs revealed facilitators to MOUD adoption, such as strong leadership that champions the implementation to staff and redefining recovery from substance use disorders throughout the organization. This study's findings highlight that clients, clinicians, and leadership need to address both practical and ideological barriers to expanding MOUD use.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  MOUD; Nonadopter; Opioid use disorder; Publicly funded treatment; Treatment facility

Mesh:

Year:  2020        PMID: 33298303      PMCID: PMC7808060          DOI: 10.1016/j.jsat.2020.108176

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  35 in total

1.  Medications For Addiction Treatment: Changing Language to Improve Care.

Authors:  Sarah E Wakeman
Journal:  J Addict Med       Date:  2017 Jan/Feb       Impact factor: 3.702

2.  Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.

Authors:  Michael L Barnett; Josh Gray; Anna Zink; Anupam B Jena
Journal:  N Engl J Med       Date:  2017-12-14       Impact factor: 91.245

Review 3.  Can We Pay for Performance in Behavioral Health Care?

Authors:  Rebecca E Stewart; Ishara Lareef; Trevor R Hadley; David S Mandell
Journal:  Psychiatr Serv       Date:  2016-12-01       Impact factor: 3.084

4.  Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.

Authors:  Adam Bisaga; Paolo Mannelli; Miao Yu; Narinder Nangia; Christine E Graham; D Andrew Tompkins; Thomas R Kosten; Sarah C Akerman; Bernard L Silverman; Maria A Sullivan
Journal:  Drug Alcohol Depend       Date:  2018-04-10       Impact factor: 4.492

5.  Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.

Authors:  Ramin Mojtabai; Christine Mauro; Melanie M Wall; Colleen L Barry; Mark Olfson
Journal:  Health Aff (Millwood)       Date:  2019-01       Impact factor: 6.301

Review 6.  Combining medically assisted treatment and Twelve-Step programming: a perspective and review.

Authors:  Marc Galanter
Journal:  Am J Drug Alcohol Abuse       Date:  2017-04-07       Impact factor: 3.829

7.  Interesting practitioners in training in empirically supported treatments: research reviews versus case studies.

Authors:  Rebecca E Stewart; Dianne L Chambless
Journal:  J Clin Psychol       Date:  2010-01

8.  Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

Authors:  Sandra D Comer; Maria A Sullivan; Elmer Yu; Jami L Rothenberg; Herbert D Kleber; Kyle Kampman; Charles Dackis; Charles P O'Brien
Journal:  Arch Gen Psychiatry       Date:  2006-02

9.  Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results.

Authors:  Larissa J Mooney; Jonathan Valdez; Sarah J Cousins; Caroline Yoo; Yuhui Zhu; Yih-Ing Hser
Journal:  J Subst Abuse Treat       Date:  2019-10-24

10.  Advancing a conceptual model of evidence-based practice implementation in public service sectors.

Authors:  Gregory A Aarons; Michael Hurlburt; Sarah McCue Horwitz
Journal:  Adm Policy Ment Health       Date:  2011-01
View more
  1 in total

1.  Residential treatment and medication treatment for opioid use disorder: The role of state Medicaid innovations in advancing the field.

Authors:  Peggy L O'Brien; Maureen T Stewart; Morgan C Shields; Mackenzie White; Joel Dubenitz; Judith Dey; Norah Mulvaney-Day
Journal:  Drug Alcohol Depend Rep       Date:  2022-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.